针对抗抗性高度血清性卵巢癌的基于抗体的免疫疗法的发展
Zivile Giedraityte1, Noora Aarnio2, Faez Amokrane Nait Mohamed3
1Faculty of Medicine, University of Helsinki, Helsinki, 00290, Finland. zivile.giedraityte@helsinki.fi.
Scientific reports
|November 29, 2025
概括
基于抗体的疗法在治疗抗性卵巢癌方面表现有前途. 这些疗法有效地杀死癌细胞,无论它们对制药的耐药性或同源重组状态如何.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 表皮卵巢癌 (EOC) 是妇科癌症死亡的主要原因.
- 晚期诊断和 (Pt) 耐药性疾病有助于低生存率.
- 对于抗高度血清性卵巢癌 (HGSOC) 需要新的治疗策略.
研究的目的:
- 评估基于抗体的治疗对抗白金耐药和白金敏感的HGSOC细胞系的疗效.
- 研究补体激活和膜攻击复合体 (MAC) 形成在抗体介导细胞杀死中的作用.
- 确定化疗耐药性是否影响HGSOC.抗体治疗的有效性.
主要方法:
- 在HGSOC细胞系 (OVCAR-3,OVCAR-8,OVCAR-4) 上测试了S2和Yth53.1的抗体,其度不同.
- 细胞溶解量化使用不透的染料 (7-Aminoactinomycin D,Annexin V).
- 评估了CD59作为MAC抑制剂的功能,并监测了MAC组合.
主要成果:
- 抗体S2通过补体激活表现出细胞毒性作用.
- 抗体Yth53.1中和了CD59,使MAC组装和细胞溶解成为可能.
- 对抗 Pt 抵抗性和 Pt 敏感性 HGSOC 细胞的两种抗体都观察到显著的杀死效率,无论同源重组 (HR) 能力如何.
- 化疗耐药性并没有阻碍基于抗体的疗法的有效性.
结论:
- 基于抗体的疗法,包括S2和Yth53.1,对抗抗性HGSOC有效.
- 这些疗法绕过了的抗性机制.
- 这项研究突出了基于抗体治疗抗性HGSOC的潜力.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.8K
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
18.8K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K